AbbVie’s Imbruvica victory at Federal Circuit adds to Humira successes
The company’s latest win means that its second highest selling drug will not face US competition for a decade
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.